Seguir
Marvin Gee
Marvin Gee
3T Biosciences
Dirección de correo verificada de alumni.stanford.edu
Título
Citado por
Citado por
Año
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
JA Fraietta, CL Nobles, MA Sammons, S Lundh, SA Carty, TJ Reich, ...
Nature 558 (7709), 307-312, 2018
6902018
Antigen identification for orphan T cell receptors expressed on tumor-infiltrating lymphocytes
MH Gee, A Han, SM Lofgren, JF Beausang, JL Mendoza, ME Birnbaum, ...
Cell 172 (3), 549-563. e16, 2018
2712018
Isolation of a structural mechanism for uncoupling T cell receptor signaling from peptide-MHC binding
LV Sibener, RA Fernandes, EM Kolawole, CB Carbone, F Liu, D McAffee, ...
Cell 174 (3), 672-687. e27, 2018
2602018
Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity
JJ Adams, S Narayanan, ME Birnbaum, SS Sidhu, SJ Blevins, MH Gee, ...
Nature immunology 17 (1), 87-94, 2016
1302016
Identification of a functional docking site in the Rpn1 LRR domain for the UBA-UBL domain protein Ddi1
TA Gomez, N Kolawa, M Gee, MJ Sweredoski, RJ Deshaies
BMC biology 9 (1), 1-15, 2011
892011
T cell receptor cross-reactivity expanded by dramatic peptide–MHC adaptability
TP Riley, LM Hellman, MH Gee, JL Mendoza, JA Alonso, KC Foley, ...
Nature chemical biology 14 (10), 934-942, 2018
802018
Domain-swapped T cell receptors improve the safety of TCR gene therapy
MT Bethune, MH Gee, M Bunse, MS Lee, EH Gschweng, MS Pagadala, ...
Elife 5, e19095, 2016
592016
Tuning T cell receptor sensitivity through catch bond engineering
X Zhao, EM Kolawole, W Chan, Y Feng, X Yang, MH Gee, KM Jude, ...
Science 376 (6589), eabl5282, 2022
582022
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro
MH Gee, LV Sibener, ME Birnbaum, KM Jude, X Yang, RA Fernandes, ...
Proceedings of the National Academy of Sciences 115 (31), E7369-E7378, 2018
262018
Identification of antigenic targets
HP Gerber, LV Sibener, LJ Lee, MH Gee
Trends in cancer 6 (4), 299-318, 2020
92020
Intracellular targets as source for cleaner targets for the treatment of solid tumors
HP Gerber, LV Sibener, LJ Lee, M Gee
Biochemical pharmacology 168, 275-284, 2019
92019
Facile method for screening clinical T cell receptors for off-target peptide-HLA reactivity
MH Gee, X Yang, KC Garcia
bioRxiv, 472480, 2018
82018
Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity
JL Mendoza, S Fischer, MH Gee, LH Lam, S Brackenridge, FM Powrie, ...
Elife 9, e58128, 2020
52020
Domain-swap T cell receptors
MT Bethune, MH Gee, D Baltimore
US Patent 9,884,075, 2018
52018
Computational and Systems Immunology: A Student’s Perspective
Z Good, J Glanville, MH Gee, MM Davis, P Khatri
Trends in immunology 40 (8), 665-668, 2019
32019
Stabilization of ribozyme-like cis-noncoding rRNAs induces apoptotic and nonapoptotic death in lung cells
M Gee, Y Gu, JR Fields, YH Shiao
Cell death & disease 3 (3), e281-e281, 2012
32012
Isolation and visualization of a structural trigger that uncouples TCR signaling from pMHC binding
LV Sibener, RA Fernandes, EM Kolawole, CB Carbone, F Liu, D McAffee, ...
Cell 174 (3), 672, 2018
22018
Antigen Discovery for T Cell Receptors Isolated from Patient Tumors Recognizing Wild-Type Antigens and Potent Peptide Mimotopes
M Gee, MM Davis, A Han, KC Garcia
US Patent App. 16/492,898, 2020
12020
Improving anti-tumor immunity by engineering T cell receptors to prevent mispairing (VAC7P. 1033)
M Bethune, M Gee, M Lee, M Kuhns, D Baltimore
The Journal of Immunology 194 (1_Supplement), 143.3-143.3, 2015
12015
403 Rapid and multiplexed identification of novel TCRs for TCR-T cell therapy
T Moore, B Hegde, J Leonard, N Katz, A Sharathchandra, B Xie, J Dreux, ...
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
2022
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20